POGK, also known as pogo transposable element with KRAB domain, is a protein with diverse roles in cellular processes, primarily implicated in transcriptional regulation and chromatin organization. POGK contains a KRAB (Krüppel-associated box) domain, which is commonly found in transcriptional repressors, suggesting its involvement in gene expression regulation. Additionally, POGK contains a pogo transposable element-derived domain, although its precise function remains to be fully elucidated. Studies have indicated that POGK may interact with chromatin-modifying enzymes and transcription factors, influencing the accessibility of DNA to the transcriptional machinery and thereby regulating gene expression patterns. Furthermore, POGK has been implicated in various cellular processes, including cell proliferation, differentiation, and development, suggesting its importance in fundamental biological processes.
The activation of POGK is likely regulated through complex mechanisms involving post-translational modifications and protein-protein interactions. One mechanism of POGK activation is through phosphorylation, acetylation, or other post-translational modifications that may alter its protein conformation, stability, or subcellular localization. These modifications may modulate POGK's ability to interact with other proteins or DNA, influencing its transcriptional regulatory functions. Additionally, POGK activation may be regulated by its association with cofactors or regulatory proteins that facilitate its recruitment to specific genomic loci or chromatin regions, thereby modulating its transcriptional activity. Furthermore, environmental cues and cellular signaling pathways may also influence POGK activation by regulating its expression levels or modifying its interacting partners. Overall, elucidating the mechanisms of POGK activation will provide valuable insights into its role in transcriptional regulation and chromatin dynamics, with implications for understanding cellular processes and disease mechanisms.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to increased cAMP levels. POGK, a known cAMP responsive element binding protein (CREB) target gene, can have its functionality enhanced by Forskolin through the increased activity of CREB. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, which prevents the degradation of cAMP, leading to increased intracellular cAMP levels. POGK, being a CREB target gene, can have its functional activity enhanced by IBMX via increased CREB activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is an activator of Protein Kinase C (PKC). POGK, known to be regulated by PKC, can have its functionality enhanced by PMA through the increased activity of PKC. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases. By inhibiting these phosphatases, okadaic acid can enhance the phosphorylation status of POGK, leading to its activation. | ||||||
Rottlerin | 82-08-6 | sc-3550 sc-3550B sc-3550A sc-3550C sc-3550D sc-3550E | 10 mg 25 mg 50 mg 1 g 5 g 20 g | $84.00 $166.00 $302.00 $2091.00 $5212.00 $16657.00 | 51 | |
Rottlerin is a PKCδ inhibitor. PKCδ is another protein that POGK interacts with. By inhibiting PKCδ, Rottlerin can increase POGK's relative activity by reducing competition for binding sites. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Vinblastine disrupts microtubule dynamics. POGK is known to be associated with microtubule-associated processes, thus vinblastine can logically enhance POGK activity by affecting these processes. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts the Golgi apparatus and affects vesicle trafficking. As POGK is involved in vesicle trafficking, its activity can be logically enhanced by Brefeldin A. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubules. As POGK is involved in microtubule-associated processes, its activity can be logically enhanced by influencing microtubule dynamics. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
As an inhibitor of glycolysis, 2-Deoxy-D-glucose can alter cellular energy status and thus can influence POGK's activity within the cell. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine affects clathrin-mediated endocytosis, a process in which POGK is involved. It can logically enhance POGK activity by influencing endocytic processes. | ||||||